• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

山茱萸苷 A 特异性结合核糖体蛋白 S3a,并抑制巨噬细胞中 LPS 诱导的信号转导。

Esculentoside A specifically binds to ribosomal protein S3a and impairs LPS-induced signaling in macrophages.

机构信息

College of Pharmacy, Second Military Medical University, Shanghai 200433, China.

College of Pharmacy, Second Military Medical University, Shanghai 200433, China; Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.

出版信息

Int Immunopharmacol. 2018 Jan;54:254-260. doi: 10.1016/j.intimp.2017.11.018. Epub 2017 Nov 21.

DOI:10.1016/j.intimp.2017.11.018
PMID:29169044
Abstract

Esculentoside A (EsA), a saponin isolated from Phytolacca esculenta, is reported as a potent suppressor of pro-inflammatory functions of macrophages. However, little is known about the target proteins of EsA for its anti-inflammatory activity. In the present study, to identify the intracellular target for EsA, affinity resins bearing immobilized EsA were used to capture binding proteins of EsA from RAW264.7 cell lysates. Mass spectrography and Western blot analysis of captured proteins indicated that ribosomal protein S3a preferentially bound to EsA affinity resin. Competition experiment further demonstrated that free EsA can disturb the specific interaction between recombinant RPS3a and affinity resin. Surface Plasmon Resonance analysis confirmed that EsA directly bound to RPS3a. Lentivirus-mediated RNAi RPS3a resulted in suppression of TNF-α and IL-6 production and impediment of signal transduction in LPS-stimulated RAW264.7 cells, indicating that RPS3a is required for LPS-triggered signaling during induction of pro-inflammatory cytokines. In addition, EsA inhibited the expression of inflammatory factors more strongly in the case of RPS3a interference. These results suggest that EsA exerts its anti-inflammatory activity by targeting RPS3a and impairing its signaling function. These new findings not only extended our understanding on the intracellular mechanisms of EsA, but also indicated RPS3a as an essential component for LPS-mediated pro-inflammatory signaling, thus implying RPS3a as a novel therapeutic target for anti-inflammatory therapy.

摘要

Esculentoside A(EsA)是从商陆中分离得到的一种皂苷,据报道它是一种强大的巨噬细胞促炎功能抑制剂。然而,对于其抗炎活性的靶蛋白知之甚少。在本研究中,为了鉴定 EsA 的细胞内靶标,使用固定有 EsA 的亲和树脂从 RAW264.7 细胞裂解物中捕获 EsA 的结合蛋白。捕获蛋白的质谱和 Western blot 分析表明核糖体蛋白 S3a 优先与 EsA 亲和树脂结合。竞争实验进一步表明,游离的 EsA 可以干扰重组 RPS3a 与亲和树脂的特异性相互作用。表面等离子体共振分析证实 EsA 直接与 RPS3a 结合。慢病毒介导的 RPS3a RNAi 导致 TNF-α和 IL-6 产生的抑制以及 LPS 刺激的 RAW264.7 细胞中信号转导的受阻,表明 RPS3a 是 LPS 触发诱导促炎细胞因子信号所必需的。此外,在 RPS3a 干扰的情况下,EsA 对炎症因子的表达抑制作用更强。这些结果表明,EsA 通过靶向 RPS3a 并损害其信号转导功能发挥抗炎活性。这些新发现不仅扩展了我们对 EsA 细胞内机制的理解,还表明 RPS3a 是 LPS 介导的促炎信号的必需组成部分,因此暗示 RPS3a 是抗炎治疗的新的治疗靶点。

相似文献

1
Esculentoside A specifically binds to ribosomal protein S3a and impairs LPS-induced signaling in macrophages.山茱萸苷 A 特异性结合核糖体蛋白 S3a,并抑制巨噬细胞中 LPS 诱导的信号转导。
Int Immunopharmacol. 2018 Jan;54:254-260. doi: 10.1016/j.intimp.2017.11.018. Epub 2017 Nov 21.
2
Esculentoside A suppresses lipopolysaccharide-induced pro-inflammatory molecule production partially by casein kinase 2.商陆皂苷甲通过酪蛋白激酶2部分抑制脂多糖诱导的促炎分子生成。
J Ethnopharmacol. 2017 Feb 23;198:15-23. doi: 10.1016/j.jep.2016.12.041. Epub 2016 Dec 24.
3
Esculentoside A exerts anti-inflammatory activity in microglial cells.山茱萸苷 A 可在小胶质细胞中发挥抗炎活性。
Int Immunopharmacol. 2017 Oct;51:148-157. doi: 10.1016/j.intimp.2017.08.014. Epub 2017 Aug 30.
4
Esculentoside A inhibits LPS-induced BV2 microglia activation through activating PPAR-γ.山茱萸苷 A 通过激活 PPAR-γ 抑制 LPS 诱导的 BV2 小胶质细胞活化。
Eur J Pharmacol. 2017 Oct 15;813:61-65. doi: 10.1016/j.ejphar.2017.07.029. Epub 2017 Jul 19.
5
Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ.七叶皂苷A通过激活过氧化物酶体增殖物激活受体γ(PPAR-γ)抑制脂多糖(LPS)诱导的急性肾损伤。
Microb Pathog. 2017 Sep;110:208-213. doi: 10.1016/j.micpath.2017.06.037. Epub 2017 Jun 27.
6
Esculentoside A inhibits tumor necrosis factor, interleukin-1, and interleukin-6 production induced by lipopolysaccharide in mice.商陆皂苷甲抑制小鼠体内脂多糖诱导的肿瘤坏死因子、白细胞介素-1和白细胞介素-6的产生。
Pharmacology. 1998 Apr;56(4):187-95. doi: 10.1159/000028197.
7
The protective effect of Esculentoside A on experimental acute liver injury in mice.七叶皂苷A对小鼠实验性急性肝损伤的保护作用。
PLoS One. 2014 Nov 18;9(11):e113107. doi: 10.1371/journal.pone.0113107. eCollection 2014.
8
Protective effect of esculentoside A on lipopolysaccharide-induced acute lung injury in mice.Esculentoside A 对脂多糖诱导的小鼠急性肺损伤的保护作用。
J Surg Res. 2013 Nov;185(1):364-72. doi: 10.1016/j.jss.2013.05.018. Epub 2013 May 29.
9
Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.Esculentoside A 通过阻断 IL-6/STAT3 信号通路抑制乳腺癌干细胞的生长,减弱干性并诱导细胞凋亡。
Phytother Res. 2018 Nov;32(11):2299-2311. doi: 10.1002/ptr.6172. Epub 2018 Aug 6.
10
Esculentoside A ameliorates cecal ligation and puncture-induced acute kidney injury in rats.商陆皂苷甲改善大鼠盲肠结扎穿孔诱导的急性肾损伤。
Exp Anim. 2017 Oct 30;66(4):303-312. doi: 10.1538/expanim.16-0102. Epub 2017 Jun 22.

引用本文的文献

1
Identification and analysis of pyroptosis-related key genes in heart failure.心力衰竭中细胞焦亡相关关键基因的鉴定与分析
J Cardiothorac Surg. 2025 Jul 14;20(1):300. doi: 10.1186/s13019-025-03530-7.
2
Humanized L184Q Mutated Surfactant Protein C Gene Alters Alveolar Type 2 Epithelial Cell Fate.人源化 L184Q 突变表面活性蛋白 C 基因改变肺泡 II 型上皮细胞命运。
Int J Mol Sci. 2024 Aug 9;25(16):8723. doi: 10.3390/ijms25168723.
3
Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
通过生物信息学和实验分析鉴定核糖体蛋白家族作为 NAFLD 的免疫细胞相关生物标志物。
Front Endocrinol (Lausanne). 2023 May 19;14:1161269. doi: 10.3389/fendo.2023.1161269. eCollection 2023.